Published Date: 02 Mar 2023
High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.
Read Full News1.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
2.
Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women
3.
PSA Screening May Modestly Curb Prostate Cancer Deaths
4.
Improved end-of-life conversations for cancer patients are identified by a new study.
5.
Enhanced CAR T cell therapy offers new strategy for lymphoma
1.
Dexamethasone and Life Expectancy After Pediatric Stem Cell Transplant
2.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
3.
Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights
4.
Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies
5.
Gene-Regulated Hematopoietic Restoration Technologies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
2.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
3.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
4.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation